1. Main page
  2. Pharmaceuticals
  3. BioNTech

BioNTech

9 Decision Makers · 9 Verified Contacts

biontech.com
📍 Mainz, Rheinland-Pfalz, GermanyPharmaceuticals🗓 Est. 2008👥 5001–10000 employees

About BioNTech

BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

Leadership & Decision Makers

Contact details of 9 BioNTech decision makers

Ugur Sahin

Co-Founder and CEO

Christoph Huber

Cofounder & deputy chair supervisory board

Christoph Kröner

Director DNA Process Development & Cap Technology

Özlem Türeci

Founder & CMO

Jesse Dong

Vice President, Peptide Chemistry

Andreas Kuhn

Senior Vice President RNA Biochemistry & Manufacturing

Annemarie Hanekamp

Chief Commercial Officer

Michael Boehler

Vice President Global Commercial and General Manager

Ozlem Türeci

Founder

General Emails

General company emails, e.g. customer support lines

    info@biontech.de

    General Inquiries

    compliance.business.ethics@biontech.com

    Unclassified inbox

    marketing@biontech.com

    Marketing Team

    mas@biontech.com

    Unclassified inbox

    gbloom@biontech.com

    Unclassified inbox

    globalhealthoffice@biontech.com

    Unclassified inbox

Verify BioNTech Emails

Similar Companies like BioNTech

Sartorius

sartorius.com
Biotechnology · Göttingen, Niedersachsen, Germany · Est. 1870 · 5001–10000 employees · $1B–$1000B

HQ: Göttingen, Niedersachsen, Germany

AbbVie

abbvie.com
Biotechnology · North Chicago, Illinois, United States · Est. 2013 · Above 10001 employees

HQ: North Chicago, Illinois, United States

Pfizer Venture Investments

pfizer.com
Biotechnology · New York, NY · Est. 1849 · Above 10001 employees

HQ: New York, NY

Merck

merck.com
Biotechnology · Rahway, New Jersey, United States · Est. 1891 · Above 10001 employees · $1B–$1000B

HQ: Rahway, New Jersey, United States

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 27/07/2025

biontech.com

+49 6131 90-840

Mainz, Rheinland-Pfalz, Germany

Specialization: Biopharmaceutical,
Legal Name: BioNTech AG
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Founded Date: 2008
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:BNTX
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +49 6131 90-840
Last Investment Activity: Mar 28, 2024
Investments Activity: Mar 28, 2024 Mar 27, 2024 Mar 26, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.